首页> 外国专利> Preparing neurons from the human embryonal teratocarcinoma cell line NT2, useful in research and for transplantation e.g. in neurodegenerative disease, by culturing as spheres then inducing differentiation

Preparing neurons from the human embryonal teratocarcinoma cell line NT2, useful in research and for transplantation e.g. in neurodegenerative disease, by culturing as spheres then inducing differentiation

机译:由人胚胎畸胎癌细胞系NT2制备神经元,可用于研究和移植,例如在神经退行性疾病中,通过培养为球体然后诱导分化

摘要

Preparation of neurons (A) from the cell line NT2 (human embryonal teratocarcinoma) that can differentiate, to (A) in particular. Preparation of neurons (A) from a cell line that can differentiate to produce (A), in particular, comprises culturing the cells as spheres, preferably with exposure to growth factors such as epidermal growth factor (EGF) and/or basic fibroblast growth factor (bFGF), in a growth medium, then inducing differentiation of the spheres by spreading them on an adhesive substrate (after removing the growth factors) and culturing in a growth medium. The new feature is that the cell line NT2 (human embryonal teratocarcinoma) is used. ACTIVITY : Neuroprotective; Cerebroprotective; Vulnerary; Ophthalmological. No details of tests for these activities are given. MECHANISM OF ACTION : Replacement of neurons.
机译:从可分化为(A)的NT2细胞系(人类胚胎畸胎癌)制备神经元(A)。从可分化产生(A)细胞的细胞系制备神经元(A),特别是包括将细胞作为球体培养,优选暴露于诸如表皮生长因子(EGF)和/或碱性成纤维细胞生长因子的生长因子下(bFGF)在生长培养基中,然后通过将球散布在粘性基质上(除去生长因子后)并在生长培养基中培养来诱导球的分化。新功能是使用细胞系NT2(人类胚胎性畸胎癌)。活动:具有神经保护作用;脑保护伤药;眼科的没有提供这些活动的测试详细信息。作用机理:神经元替代。

著录项

  • 公开/公告号FR2859219A1

    专利类型

  • 公开/公告日2005-03-04

    原文格式PDF

  • 申请/专利权人 PRIVAT ALAIN;

    申请/专利号FR20030010382

  • 申请日2003-09-02

  • 分类号C12N5/02;A61K35/30;C12N5/08;

  • 国家 FR

  • 入库时间 2022-08-21 21:58:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号